1. Home
  2. NEU vs NUVL Comparison

NEU vs NUVL Comparison

Compare NEU & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NewMarket Corp

NEU

NewMarket Corp

HOLD

Current Price

$647.28

Market Cap

6.7B

Sector

Industrials

ML Signal

HOLD

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$105.96

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEU
NUVL
Founded
1887
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
7.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NEU
NUVL
Price
$647.28
$105.96
Analyst Decision
Strong Buy
Analyst Count
0
15
Target Price
N/A
$135.00
AVG Volume (30 Days)
149.1K
548.0K
Earning Date
02-11-2026
02-26-2026
Dividend Yield
1.87%
N/A
EPS Growth
5.10
N/A
EPS
47.34
N/A
Revenue
$2,744,413,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.58
N/A
Revenue Growth
N/A
N/A
52 Week Low
$480.57
$55.54
52 Week High
$875.97
$112.88

Technical Indicators

Market Signals
Indicator
NEU
NUVL
Relative Strength Index (RSI) 28.49 54.35
Support Level $691.17 $97.43
Resistance Level $730.51 $108.65
Average True Range (ATR) 23.07 4.63
MACD -3.51 0.48
Stochastic Oscillator 14.88 79.92

Price Performance

Historical Comparison
NEU
NUVL

About NEU NewMarket Corp

NewMarket Corp is a holding company that, through its subsidiaries, manufactures and sells petroleum additives. Petroleum additives are used in lubricating oils and fuels to enhance their performance in machinery, vehicles, and other equipment. It comprises two broad product applications. Lubricant additives are formulated chemical solutions that, when blended with base fluids, improve the efficiency, durability, performance, and functionality of mineral oils, synthetic oils, and biodegradable fluids. Fuel additives are chemical components that help oil refiners meet fuel specifications or formulated packages that improve the performance of gasoline, diesel, biofuels, and other fuels.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: